These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32634387)

  • 21. Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease.
    Steensig K; Pareek M; Krarup AL; Sogaard P; Maeng M; Tayal B; Lee CJ; Torp-Pedersen C; Lip GY; Holland-Fischer P; Kragholm KH
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101952. PubMed ID: 35609823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials.
    Proietti M; Lip GY
    Am J Med; 2016 Oct; 129(10):1110-6. PubMed ID: 27086494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study.
    Schmidt M; Bøtker HE; Pedersen L; Sørensen HT
    Eur J Epidemiol; 2014 Feb; 29(2):111-8. PubMed ID: 24337942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The predictive role of CHA2DS2-VASc score between venous thromboembolism and ischemic stroke: a large-scale cohort study.
    Hu WS; Lin CL
    J Hypertens; 2018 Mar; 36(3):628-633. PubMed ID: 28858980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body mass index and adverse events in patients with incident atrial fibrillation.
    Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Lip GY; Larsen TB
    Am J Med; 2013 Jul; 126(7):640.e9-17. PubMed ID: 23601271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study.
    Overvad TF; Skjøth F; Lip GY; Lane DA; Albertsen IE; Rasmussen LH; Larsen TB
    Stroke; 2015 Aug; 46(8):2168-74. PubMed ID: 26152296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHA
    Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CHA
    Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB
    J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study.
    Fangel MV; Nielsen PB; Larsen TB; Christensen B; Overvad TF; Lip GYH; Goldhaber SZ; Jensen MB
    Int J Cardiol; 2018 Oct; 268():137-142. PubMed ID: 30041778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy.
    Hansen ML; Jepsen RM; Olesen JB; Ruwald MH; Karasoy D; Gislason GH; Hansen J; Køber L; Husted S; Torp-Pedersen C
    Europace; 2015 Jan; 17(1):18-23. PubMed ID: 25231909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
    Själander S; Svensson PJ; Friberg L
    Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy.
    Gupta DK; Giugliano RP; Ruff CT; Claggett B; Murphy S; Antman E; Mercuri MF; Braunwald E; Solomon SD;
    J Am Soc Echocardiogr; 2016 Jun; 29(6):537-44. PubMed ID: 27106009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
    Lip GY; Skjøth F; Rasmussen LH; Larsen TB
    J Am Coll Cardiol; 2015 Apr; 65(14):1385-94. PubMed ID: 25770314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
    Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
    BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
    Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
    Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
    Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.
    Steensig K; Olesen KKW; Thim T; Nielsen JC; Jensen SE; Jensen LO; Kristensen SD; Bøtker HE; Lip GYH; Maeng M
    Thromb Haemost; 2018 Dec; 118(12):2162-2170. PubMed ID: 30419601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.
    Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH
    Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.